Survivalc
|
|
|
|
|
|
|
Survival during 2 hours after birth* |
612 (95.8) |
552 (88.7) |
2.87
(1.54-5.37) |
0.001 |
3.13 (1.57-6.22) |
0.001 |
Survival to discharge* |
607 (95.0) |
545 (87.6) |
2.68 (1.49-4.82) |
0.001 |
2.82 (1.46-5.44) |
0.002 |
Neonatal characteristicsa
|
(N=632) |
(N=564) |
|
|
|
|
Gender (male) * |
324/616 (52.6) |
291/560 (53.5) |
|
|
|
|
Birth weight (gram) † |
1851 ± 472 |
2307 ± 545 |
|
|
|
|
Apgar score at 5min <7* |
52/623 (8.3) |
33/563 (5.9) |
1.47
(0.84-2.57) |
0.176 |
1.70 (0.96-3.01) |
0.067 |
NIUC admission* |
313/621 (50.4) |
201/553 (36.3) |
1.83 (1.32-2.53) |
<0.001 |
1.58 (1.12-2.24) |
0.010 |
Morbidity during hospitalizationb
|
(N=593) |
(N=526) |
|
|
|
|
Neonatal sepsis* |
10 (1.7) |
27 (5.1) |
0.32 (0.13-0.82) |
0.017 |
0.36
(0.16-0.76) |
0.009 |
Intracerebral hemorrhage* |
11 (1.9) |
15 (2.9) |
0.61 (0.21-1.77) |
0.364 |
0.79 (0.29-2.16) |
0.645 |
Retinopathy of prematurity* |
26 (4.4) |
35 (6.7) |
0.67 (0.33-1.37) |
0.272 |
0.66 (0.30-1.41) |
0.282 |
Patent ductus arteriosus* |
65 (11.0) |
23 (4.4) |
2.57 (1.40-4.70) |
0.002 |
2.63 (1.39-5.00) |
0.003 |
Pulmonary hypertension* |
8 (1.3) |
1 (0.2) |
6.08 (0.72-51.62) |
0.098 |
6.91 (1.51-65.49) |
0.019 |
Respiratory distress syndrome* |
86 (14.5) |
85 (16.2) |
0.88
(0.57-1.36) |
0.566 |
0.92 (0.56-1.51) |
0.741 |
Bronchopulmonary dysplasia* |
26 (4.4) |
4 (0.8) |
6.56 (1.69-25.51) |
0.007 |
4.23 (1.59-13.86) |
0.006 |
Necrotizing enterocolitis* |
5 (0.8) |
3 (0.6) |
1.42 (0.31-6.61) |
0.654 |
1.65 (0.41-7.47) |
0.441 |
Composite morbidity during hospitalization* |
113 (19.1) |
105 (20.0) |
0.94 (0.64-1.39) |
0.763 |
0.96 (0.62-1.49) |
0.844 |
Morbidity at present |
(N=451) |
(N=507) |
|
|
|
|
Developmental delay* |
9 (2.0) |
20 (3.9) |
0.50 (0.20-1.27) |
0.147 |
0.47 (0.20-1.11) |
0.087 |
Cerebral palsy* |
2 (0.4) |
10 (2.0) |
0.22 (0.05-1.03) |
0.055 |
0.41
(0.08-1.45) |
0.179 |